145 related articles for article (PubMed ID: 23959669)
1. Over-dialysis plasma RANTES increase depends on heparin dose and cardiovascular disease status.
Naumnik B; Koc-Żórawska E; Myśliwiec M
Adv Med Sci; 2013; 58(2):311-9. PubMed ID: 23959669
[TBL] [Abstract][Full Text] [Related]
2. Different effect of unfractionated heparin and enoxaparin on circulating proangiogenic factors during hemodialysis: A cross-over study.
Naumnik B; Pawlak K; Myśliwiec M
Cytokine; 2007 Nov; 40(2):98-104. PubMed ID: 17920287
[TBL] [Abstract][Full Text] [Related]
3. Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study.
Naumnik B; Pawlak K; Myśliwiec M
Thromb Res; 2009 Feb; 123(4):631-6. PubMed ID: 18234290
[TBL] [Abstract][Full Text] [Related]
4. Effect of unfractionated and low-molecular-weight heparin on OPG, sRANKL, and von Willebrand factor concentrations during hemodialysis.
Klejna K; Naumnik B; Koc-Żórawska E; Myśliwiec M
Clin Appl Thromb Hemost; 2014 May; 20(4):433-41. PubMed ID: 23104956
[TBL] [Abstract][Full Text] [Related]
5. Enoxaparin but not unfractionated heparin causes a dose-dependent increase in plasma TGF-beta 1 during haemodialysis: a cross-over study.
Naumnik B; Borawski J; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2007 Jun; 22(6):1690-6. PubMed ID: 17389624
[TBL] [Abstract][Full Text] [Related]
6. Unfractionated heparin but not enoxaparin causes delayed plasma PAI-1 depletion in hemodialysis patients: a prospective study.
Naumnik B; Pawlak K; Mys'liwiec M
Clin Appl Thromb Hemost; 2009 Feb; 15(1):84-91. PubMed ID: 17895513
[TBL] [Abstract][Full Text] [Related]
7. Unexpected and striking effect of heparin-free dialysis on cytokine release.
Rydzewska-Rosolowska A; Gozdzikiewicz-Lapinska J; Borawski J; Koc-Zorawska E; Mysliwiec M; Naumnik B
Int Urol Nephrol; 2017 Aug; 49(8):1447-1452. PubMed ID: 28425077
[TBL] [Abstract][Full Text] [Related]
8. Different effects of enoxaparin and unfractionated heparin on extrinsic blood coagulation during haemodialysis: a prospective study.
Naumnik B; Borawski J; Myśliwiec M
Nephrol Dial Transplant; 2003 Jul; 18(7):1376-82. PubMed ID: 12808176
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of single bolus anticoagulation with enoxaparin for chronic hemodialysis. Results of an open-label post-certification study.
Klingel R; Schwarting A; Lotz J; Eckert M; Hohmann V; Hafner G
Kidney Blood Press Res; 2004; 27(4):211-7. PubMed ID: 15273423
[TBL] [Abstract][Full Text] [Related]
10. Vascular adhesion protein-1 in hemodialysis and hemodiafiltration patients: effect of single hemodialysis session on its level in regard to type of anticoagulant.
Malyszko J; Koc-Zorawska E; Kozminski P; Malyszko JS
Int Urol Nephrol; 2017 May; 49(5):875-879. PubMed ID: 28044236
[TBL] [Abstract][Full Text] [Related]
11. High plasma endostatin level unaffected by low-molecular weight heparin in hemodialysis patients--a preliminary report.
Rydzewska-Rosolowska A; Borawski J; Mysliwiec M
Adv Med Sci; 2009; 54(2):199-202. PubMed ID: 19758969
[TBL] [Abstract][Full Text] [Related]
12. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patients.
Pon TK; Dager WE; Roberts AJ; White RH
Thromb Res; 2014 Jun; 133(6):1023-8. PubMed ID: 24718051
[TBL] [Abstract][Full Text] [Related]
14. Different effects of enoxaparin, nadroparin, and dalteparin on plasma TFPI during hemodialysis: a prospective crossover randomized study.
Naumnik B; Rydzewska-Rosołowska A; Myśliwiec M
Clin Appl Thromb Hemost; 2011 Oct; 17(5):480-6. PubMed ID: 20682597
[TBL] [Abstract][Full Text] [Related]
15. Activation of hepatocyte growth factor/activin A/follistatin system during hemodialysis: role of heparin.
Borawski J; Naumnik B; Myśliwiec M
Kidney Int; 2003 Dec; 64(6):2229-37. PubMed ID: 14633147
[TBL] [Abstract][Full Text] [Related]
16. High-dose tirofiban with enoxaparin and inflammatory markers in high-risk percutaneous intervention.
Walters DL; Ray MJ; Wood P; Perrin EJ; Bett JH; Aroney CN
Eur J Clin Invest; 2010 Feb; 40(2):139-47. PubMed ID: 20039931
[TBL] [Abstract][Full Text] [Related]
17. Elevated hepatocyte growth factor levels at the beginning of high-flux hemodialysis are due to heparin administration.
Christidou F; Bamichas G; Galaktidou G; Fragidis S; Gionanlis L; Frangia T; Bischiniotis T; Sombolos K
Ren Fail; 2008; 30(9):861-4. PubMed ID: 18925524
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
[TBL] [Abstract][Full Text] [Related]
20. Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes.
Vila V; Martínez-Sales V; Réganon E; Peris E; Perez F; Ruano M; Aznar J
Haematologica; 2001 Jul; 86(7):729-34. PubMed ID: 11454528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
